Concord biotech ipo: Subscription Status Concord Biotech

Concord Biotech IPO Subscription Status Concord Biotech IPO subscribed 24.87 times. The public issue subscribed 3.78 times in the retail category, 67.67 times in QIB, and 16.99 times in the NII category by August 8, 2023 7:02:00 PM (Day 3). Get details on the Concord Biotech Limited IPO , including IPO dates, listing date, share price range, lot size, allotment status and company financial insights. Concord Biotech IPO GMP today. Find out Concord Biotech IPO grey market premium, kostak, subject to sauda rates with expected listing gain. Concord Biotech IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1551.00 Cr. The company is based in Ahmedabad and caters to Pharmaceutical sector. Citigroup Global Markets India , Jefferies India , Kotak Mahindra Capital Company are the merchant bankers of Concord Biotech IPO . It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 12th August 2022. Concord Biotech IPO open date is 4th August 2023 and close date is 8th August 2023. IPO ...